Osang Healthcare Co.,Ltd (KOSDAQ: 036220)

Market Cap	187.45B
Revenue (ttm)	75.32B
Net Income (ttm)	-13.34B
Shares Out	13.99M
EPS (ttm)	-1,046.59
PE Ratio	n/a
Forward PE	n/a
Dividend	4,000.00 (30.79%)
Ex-Dividend Date	n/a

Volume	67,595
Open	12,870
Previous Close	12,990
Day's Range	12,870 - 13,390
52-Week Range	12,500 - 45,000
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2024

About Osang Healthcare Co.,Ltd

Osang Healthcare Co.,Ltd researches, develops, and sells various diagnostic biosensors in South Korea and internationally. The company offers diagnostic biosensors for blood glucose, hemoglobin A1c, cholesterol, immuno diagnosis, molecular diagnosis, and others. It also exports its products to approximately 110 countries worldwide. The company was formerly known as Infopia Co., Ltd. and changed its name to Osang Healthcare Co.,Ltd in April 2017. Osang Healthcare Co.,Ltd was founded in 1996 and is headquartered in Anyang, South Korea.

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1996
• Employees: 325
• Stock Exchange: KOSDAQ
• Ticker Symbol: 036220

Financial Performance

In 2023, Osang Healthcare Co.,Ltd's revenue was 355.85 billion, an increase of 83.53% compared to the previous year's 193.89 billion. Earnings were 116.44 billion, an increase of 186.46%.